Tennis Elbow (Lateral Epicondylitis) Medications in Personal Injury Cases

Amar Lunagaria — Co-Founder & Chief Pharmacist, LienScripts | March 4, 2026 | 6 min read

Lateral epicondylitis — tennis elbow — develops after impact injuries, falls on outstretched hands, and repetitive strain from post-accident compensatory movement. Learn which medications treat this condition and how a pharmacy lien documents the full treatment arc.

Lateral epicondylitis, commonly known as tennis elbow, is an overuse or traumatic injury to the extensor tendons that attach to the lateral epicondyle of the elbow. In personal injury cases, this condition arises from direct elbow trauma during car crashes, falls on outstretched hands, and repetitive compensatory gripping or lifting patterns that develop after primary injuries to the shoulder, wrist, or cervical spine.

• Lateral epicondylitis causes chronic outer-elbow pain that worsens with gripping, lifting, and forearm rotation — activities required for most occupations and daily tasks
• Treatment typically spans six weeks to six months, with medications addressing inflammation, pain, and muscle tension throughout
• A pharmacy lien through LienScripts covers every prescription at zero upfront cost, with the lien satisfied from settlement proceeds
• LienScripts generates a MERIT (Medication Evaluation & Rationale for Injury Treatment) report for every case, providing pharmacist-signed documentation for demand packages
• As Amar Lunagaria, PharmD, LienScripts' Chief Pharmacist explains, "The medication timeline for lateral epicondylitis directly maps to functional impairment — every refill represents continued inability to perform normal activities"

How Tennis Elbow Develops After an Accident

Tennis elbow in personal injury cases typically arises through two mechanisms:

Direct trauma — a fall on an outstretched hand (FOOSH injury) or a direct blow to the lateral elbow during a collision can cause acute microtearing of the extensor carpi radialis brevis tendon at its origin on the lateral epicondyle. The impact creates an inflammatory response that, if not properly managed, transitions into chronic tendinopathy.

Compensatory overuse — patients recovering from shoulder injuries, wrist fractures, or cervical spine trauma frequently alter their movement patterns to protect the primary injury. This compensatory loading shifts stress to the elbow extensors, creating a secondary injury that may not become symptomatic for weeks after the accident. Defense counsel often challenges the causal connection, making consistent medication documentation critical.

Acute Phase Medications (Weeks 1-4)

Oral NSAIDs are the cornerstone of early treatment. Naproxen, ibuprofen, or meloxicam reduce the inflammatory component of tendon pain. Celecoxib offers an alternative for patients with GI sensitivity. Prescription-strength dosing is typically necessary because over-the-counter doses do not adequately control tendon inflammation.

Topical NSAIDs — diclofenac gel or topical ketoprofen — deliver anti-inflammatory medication directly to the lateral epicondyle. Topical application is particularly effective for lateral epicondylitis because the affected tendons are superficial and accessible to transdermal drug delivery.

Acetaminophen provides supplemental pain control for patients who cannot tolerate full-dose oral NSAIDs or who need around-the-clock baseline analgesia.

Muscle relaxants are prescribed when the forearm extensors develop protective spasm. Cyclobenzaprine or methocarbamol at bedtime reduces nocturnal forearm tension and improves sleep quality — important because many patients report waking when they inadvertently grip the pillow or sheets.

Corticosteroid injection — while not a pharmacy-dispensed medication in most cases, a single injection of triamcinolone or methylprednisolone into the lateral epicondyle region is a common early intervention. The prescribing provider may also prescribe oral methylprednisolone (a Medrol dose pack) as an alternative to injection for patients who prefer to avoid needles.

Subacute and Rehabilitation Phase (Weeks 4-12)

As physical therapy and occupational therapy begin, the medication protocol shifts toward supporting progressive loading of the healing tendons.

As-needed oral NSAIDs continue but at reduced frequency. Patients take them before or after therapy sessions that involve eccentric loading exercises — the primary evidence-based rehabilitation approach for lateral epicondylitis.

Topical diclofenac gel becomes the primary pharmacologic tool during this phase. Application before and after PT sessions, and as needed during the workday, provides anti-inflammatory coverage without systemic side effects.

Compounded topical preparations may include combinations of ketoprofen, gabapentin, and lidocaine in a transdermal cream, offering multi-mechanism pain relief at the epicondyle. These compounded formulations are commonly used when standard topical NSAIDs provide incomplete relief.

Gabapentin is introduced if patients develop neuropathic features — burning, tingling, or shooting pain radiating down the forearm. The posterior interosseous nerve runs through the supinator muscle near the lateral epicondyle and can become irritated by chronic inflammation or scar tissue.

Chronic Phase Management (Months 3-6+)

Lateral epicondylitis that persists beyond twelve weeks despite conservative treatment enters the chronic phase, where the underlying pathology transitions from inflammatory tendinitis to degenerative tendinosis.

Continued topical NSAID use remains appropriate for activity-related pain. Low-dose gabapentin may continue if neuropathic symptoms persist. Duloxetine is occasionally introduced for chronic tendon pain that has not responded to other agents, as SNRI medications have demonstrated efficacy in chronic musculoskeletal pain conditions.

Documentation Value for Settlement

The medication record for lateral epicondylitis provides powerful documentation:

• Duration — a prescription timeline extending months demonstrates the injury was not a minor bruise
• Functional impact — medication fills correlate with continued inability to grip, lift, and perform work tasks
• Treatment escalation — progression from OTC to prescription NSAIDs to topical compounded medications to neuropathic agents shows worsening or persistent pathology
• Physician contacts — each new prescription or refill represents a documented clinical encounter

The LienScripts platform captures every fill with timestamps and prescriber details, integrating into the demand package that the attorney assembles for settlement negotiation.

Related Resources

• Diclofenac for Joint Pain After a Fall
• Carpal Tunnel Surgery Medications on a Pharmacy Lien
• Compound Medications in Personal Injury Cases
• Gabapentin for Whiplash Pain After a Car Accident